Patrick Walsh - Avid Bioservices Independent Director
Director
Mr. Patrick D. Walsh serves as Independent Director of the Company. Mr. Walsh has served as a member of the Board of Directors since October 2017. He currently serves as Chief Executive Officer of Avista Pharma Solutions, a highgrowth CDMO with over 220, 000 square feet of facility space that provides pharmaceutical clients with a full suite of service offerings including analytical, microbiology, API, formulation, drug substance and drug product manufacturing expertise and capabilities. Prior to joining Avista Pharma, he was chief executive officer of AAIPharma Services, a privateequity backed CDMO at which he led a successful growth strategy culminating in the companys sale for more than 4.5 times return on invested capital. Mr. Walsh also held the positions of President and Chief Operating Officer of GensiaSicor, during which time he led the company commercial growth strategy, culminating in the eventual sale to Teva for 3.4 billion. Prior to Gensia, he spent 10 years in a global pharmaceutical company culminating in leading the U.S. and international business of a leading Japanese pharma company. Mr. Walsh has served on pharmaceutical boards as chairman, nonexecutive chairman and company director, as well as an executive advisor to private equity and VC firms since 2017.
| Age | 57 |
| Tenure | 7 years |
| Phone | 714 508 6100 |
| Web | http://www.avidbio.com |
Patrick Walsh Latest Insider Activity
Tracking and analyzing the buying and selling activities of Patrick Walsh against Avid Bioservices stock is an integral part of due diligence when investing in Avid Bioservices. Patrick Walsh insider activity provides valuable insight into whether Avid Bioservices is net buyers or sellers over its current business cycle. Note, Avid Bioservices insiders must abide by specific rules, including filing SEC forms every time they buy or sell Avid Bioservices'shares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
Patrick Walsh few days ago Disposition of 1434 shares by Patrick Walsh of Potbelly at 10.76 subject to Rule 16b-3 | ||
Patrick Walsh over a year ago Sale by Patrick Walsh of 10000 shares of BJs Restaurants |
Avid Bioservices Management Efficiency
The company has return on total asset (ROA) of 1.98 % which means that it generated a profit of $1.98 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 6.72 %, meaning that it generated $6.72 on every $100 dollars invested by stockholders. Avid Bioservices' management efficiency ratios could be used to measure how well Avid Bioservices manages its routine affairs as well as how well it operates its assets and liabilities.The company has accumulated 21.57 M in total debt with debt to equity ratio (D/E) of 0.25, which may suggest the company is not taking enough advantage from borrowing. Avid Bioservices has a current ratio of 1.82, which is within standard range for the sector. Debt can assist Avid Bioservices until it has trouble settling it off, either with new capital or with free cash flow. So, Avid Bioservices' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Avid Bioservices sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Avid to invest in growth at high rates of return. When we think about Avid Bioservices' use of debt, we should always consider it together with cash and equity.
Similar Executives
| Showing other executives | DIRECTOR Age | ||
| Robert MacLeod | Relx PLC ADR | 56 | |
| Debra Crew | Newell Brands | 47 | |
| Suzanne Wood | Relx PLC ADR | 60 | |
| Marike Lels | Relx PLC ADR | 61 | |
| Courtney Mather | Newell Brands | 41 | |
| Robert Steele | Newell Brands | 62 | |
| Wolfhart Hauser | Relx PLC ADR | 71 | |
| Andrew Langham | Newell Brands | 42 | |
| Linda Sanford | Relx PLC ADR | 68 | |
| Kevin Robbins | Mannatech Incorporated | N/A | |
| Scott Cowen | Newell Brands | 70 | |
| Frank Lin | 51Talk Online Education | 55 | |
| Ian Fraser | Relx PLC ADR | N/A | |
| Nick Luff | Relx PLC ADR | 49 | |
| Judith Sprieser | Newell Brands | 64 | |
| Christopher OLeary | Newell Brands | 55 | |
| James Craigie | Newell Brands | 64 | |
| Brett Icahn | Newell Brands | 37 | |
| Xiaoguang Wu | 51Talk Online Education | 45 | |
| Cynthia Montgomery | Newell Brands | 61 | |
| Steven Strobel | Newell Brands | 59 | |
Management Performance
| Return On Equity | 6.72 | |||
| Return On Asset | 1.98 |
Avid Bioservices Leadership Team
Elected by the shareholders, the Avid Bioservices' board of directors comprises two types of representatives: Avid Bioservices inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Avid. The board's role is to monitor Avid Bioservices' management team and ensure that shareholders' interests are well served. Avid Bioservices' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Avid Bioservices' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Shelley Fussey, Vice President - Intellectual Property | ||
| Daniel Hart, CFO | ||
| Stephen Hedberg, Principal Financial Officer, Principal Accounting Officer | ||
| Mark Ziebell, Vice President General Counsel, Corporate Secretary | ||
| Paul Lytle, CFO | ||
| Catherine Mackey, Independent Director | ||
| Roger Lias, President CEO | ||
| Gregory Sargen, Director | ||
| Mark Bamforth, Independent Director | ||
| Patrick Walsh, Independent Director | ||
| Richard Hancock, Director | ||
| Joel McComb, Director | ||
| Joseph Carleone, Director | ||
| Magnus Schroeder, Vice President - Process Sciences |
Avid Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Avid Bioservices a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Avid Bioservices in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Avid Bioservices' short interest history, or implied volatility extrapolated from Avid Bioservices options trading.
Pair Trading with Avid Bioservices
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Avid Bioservices position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Avid Bioservices will appreciate offsetting losses from the drop in the long position's value.The ability to find closely correlated positions to Microsoft could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Microsoft when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Microsoft - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Microsoft to buy it.
The correlation of Microsoft is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Microsoft moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Microsoft moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Microsoft can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in persons. You can also try the Top Crypto Exchanges module to search and analyze digital assets across top global cryptocurrency exchanges.
Other Consideration for investing in Avid Stock
If you are still planning to invest in Avid Bioservices check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Avid Bioservices' history and understand the potential risks before investing.
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance |